The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
Now Live: Breaking Research From AIDS 2008: Podcasts, Interviews, Videos & More >>
Project Inform
New Anti-HIV Drugs Receive FDA Approval

October 2003

Three anti-HIV drugs have recently been approved by the Food and Drug Administration, including one in a new class called fusion or entry inhibitor. Each adds something unique to the arsenal of therapies to treat HIV infection. The three include:


Drug NameTrade NameCompanyDrug Class
T-20, enfuvirtideFuzeonHoffman La-Roche, Trimerisentry inhibitor
FTC, emtricitabineEmtrivaGileadnucleoside analog reverse transcriptase inhibitor
AtazanavirReyatazBristol-Myers Squibbprotease inhibitor


The following articles highlight information on each of the newly approved drugs and provide a discussion on how they fit into the arsenal of existing drugs.


Back to the Project Inform Perspective October 2003 contents page.


This article was provided by Project Inform. It is a part of the publication Project Inform Perspective.